Stryker Corporation (SYK)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $118.29B
Last updated: Nov 17, 2026 at 4:37 PM ET
Stryker Corporation (SYK) Statistics
Stryker (SYK) has a market cap of $118.29B and an enterprise value of $129.95B. Its return on invested capital of 11.35% compares with a 7.46% median across 12 similar companies.
Total Valuation
Enterprise value is 9.86% above the market cap, as debt exceeds cash.
| Market Cap | $118.29B |
|---|---|
| Enterprise Value | $129.95B |
| Latest price (Nov 17, 2026) | $317.47 |
Key Dates
The next earnings report is expected on Jan 27, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 30, 2026.
| Next Earnings Date | Jan 27, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Last Ex-Dividend Date | Sep 30, 2026 |
| Last Payment Date | Oct 30, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 4.6x and 5.2x. Its year-end P/E ranged from 20.7x to 33.0x from 2016 to 2025.
| P/E Ratio | 22.2x |
|---|---|
| Forward P/E | 21.2x |
| P/S Ratio | 4.6x |
| Forward P/S | 4.4x |
| P/B Ratio | 5.2x |
| P/FCF Ratio | 26.5x |
| P/OCF Ratio | 21.7x |
| PEG Ratio | 2.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 18.1x EBITDA and 29.1x free cash flow.
| EV / Earnings | 35.9x |
|---|---|
| EV / Sales | 4.9x |
| EV / EBITDA | 18.1x |
| EV / EBIT | 21.1x |
| EV / FCF | 29.1x |
Price Statistics
The stock is down 11.90% over 52 weeks and trades 8.37% above its 50-day average.
| Beta (1Y) | 0.24 |
|---|---|
| 52-Week Change | -11.90% |
| 1-Month Change | +6.55% |
| 3-Month Change | -6.32% |
| 6-Month Change | +0.51% |
| 5-Year Change | +9.69% |
| 10-Year Change | +153.02% |
| Total Return (1Y) | -10.92% |
| Total Return (3Y CAGR) | +3.89% |
| Total Return (5Y CAGR) | +4.97% |
| Return vs SPY (1Y) | -22.80% |
| Max Drawdown (1Y) | -30.22% |
| Max Drawdown (3Y) | -33.21% |
| Sharpe Ratio (1Y) | -0.37 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $292.96 |
| 200-Day Average | $320.26 |
| 52-Week Range | $266.16 to $386.02 |
| RSI (14 Days) | 55.6 |
| Average Volume (20 Days) | 3.27M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.18x current liabilities, and total debt is 0.64x shareholder equity.
| Current Ratio | 2.18x |
|---|---|
| Quick Ratio | 1.30x |
| Debt / Equity | 0.64x |
| Debt / EBITDA | 2.03x |
| Debt / FCF | 3.26x |
| Interest Coverage | 10.50x |
Returns and Efficiency
Return on invested capital is 11.35% over the last 12 months, against a 5-year average of 9.13%.
| Return on Equity (ROE) | 15.45% |
|---|---|
| Return on Assets (ROA) | 7.67% |
| Return on Invested Capital (ROIC) | 11.35% |
| Return on Capital Employed (ROCE) | 15.11% |
| ROE (5Y Average) | 14.72% |
| ROA (5Y Average) | 6.77% |
| ROIC (5Y Average) | 9.13% |
| Asset Turnover | 0.56x |
| Inventory Turnover | 1.62x |
| Receivables Turnover | 7.07x |
| Cash Conversion Cycle | 211 days |
Taxes
Income tax took 29.18% of pretax income over the last 12 months.
| Income Tax (TTM) | $1.49B |
|---|---|
| Effective Tax Rate | 29.18% |
Scores
SYK has an Altman Z-Score of 4.87, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.87 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $26.30B over the last 12 months is up 7.87% from the 12 months before.
| Revenue | $26.30B |
|---|---|
| Revenue Growth (YoY) | +7.87% |
| Gross Profit | $17.18B |
| Operating Income | $5.43B |
| Pretax Income | $5.12B |
| Net Income | $3.62B |
| EBITDA | $7.36B |
| EBIT | $6.16B |
| Reported EPS (TTM) | $14.28 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 49.65% of the $47.25B in total assets.
| Cash and Equivalents | $3.27B |
|---|---|
| Total Debt | $14.93B |
| Net Debt | $11.66B |
| Net Debt Per Share | $30.50 |
| Working Capital | $7.68B |
| Shareholder Equity | $23.46B |
| Book Value Per Share | $61.37 |
| Tangible Book Value | -$1.41B |
| Total Assets | $47.25B |
| Total Liabilities | $23.79B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $873.00M of capital spending, operating cash flow left $4.57B of free cash flow.
| Operating Cash Flow | $5.45B |
|---|---|
| Capital Expenditures | $873.00M |
| Free Cash Flow | $4.57B |
| FCF Per Share | $11.92 |
| Depreciation and Amortization | $1.21B |
| Dividends Paid | $1.33B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 20.66%, against a 5-year average of 17.05%.
| Gross Margin | 65.34% |
|---|---|
| Operating Margin | 20.66% |
| Pretax Margin | 19.45% |
| Net Margin | 13.78% |
| EBITDA Margin | 27.99% |
| EBIT Margin | 23.40% |
| FCF Margin | 17.39% |
| Gross Margin (5Y Average) | 63.69% |
| Operating Margin (5Y Average) | 17.05% |
| Net Margin (5Y Average) | 13.21% |
Growth
Revenue grew 10.83% a year over 3 years, and EPS 13.43% a year.
| Revenue Growth (3Y CAGR) | +10.83% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.84% |
| EPS Growth (3Y CAGR) | +13.43% |
| EPS Growth (5Y CAGR) | +12.90% |
| FCF Growth (3Y CAGR) | +28.13% |
| FCF Growth (5Y CAGR) | +8.95% |
| Operating Income Growth (3Y CAGR) | +19.83% |
| Book Value Per Share Growth (2Y CAGR) | +9.44% |
Dividends and Yields
SYK pays out 24.70% of earnings as dividends.
| Dividend Per Share (Annual) | $3.52 |
|---|---|
| Dividend Yield | 1.11% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +6.25% |
| Dividend Growth (5Y CAGR) | +7.62% |
| Payout Ratio | 24.70% |
| FCF Payout Ratio | 29.15% |
| Earnings Yield | 4.50% |
| FCF Yield | 3.77% |
| Shareholder Yield | 1.10% |
Stock Splits
The last split was a 2-for-1 forward split on May 17, 2004.
| Last Split Date | May 17, 2004 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 9 similar companies, SYK has the 4th highest P/E.
P/E RatioPeer median 17.9x
P/S RatioPeer median 2.6x
ROICPeer median 7.46%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.19%
Dividend YieldPeer median 0.27%
| P/E Ratio | 22.2x vs 17.9x median |
|---|---|
| P/S Ratio | 4.6x vs 2.6x median |
| ROIC | 11.35% vs 7.46% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +7.87% vs +8.19% median |
| Dividend Yield | 1.11% vs 0.27% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.94% and EPS growth at 9.32% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.94% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +9.32% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SYK
What is SYK's market cap?
Stryker has a market cap of $118.29B. Its enterprise value, which adds debt and subtracts cash, is $129.95B.
What is SYK's P/E ratio?
Stryker has a trailing P/E ratio of 22.2x and a forward P/E of 21.2x.
How many shares of SYK are outstanding?
Stryker has 382.20M shares outstanding. The count is down 0.05% from a year earlier.
Does SYK pay a dividend?
Yes. Stryker pays $3.52 a share a year, a dividend yield of 1.11%.
How much debt does SYK have?
Stryker has $14.93B of total debt and $3.27B of cash and equivalents, a net debt position of $11.66B.
SYK pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts